// App-Quantinova.ai

11042 : Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.

Researchers

Presenter

  • Maristella Saponara

Principal Investigators

  • Bruno Vincenzi

  • Giuseppe Badalamenti

  • Carlo Morosi

  • Silvana Pilotti

  • Gianpaolo Dagrada

  • Salvatore Provenzano

  • Michela Libertini

  • Rossella Bertulli

  • Vittoria Colia

  • Angelo Paolo Dei Tos

  • Paolo Giovanni Casali

  • Silvia Stacchiotti

Medical Centers

  • Department of Specialized, Experimental, and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy, Bologna, Italy

  • Department of Anatomical Pathology, Campus Bio-Medico University of Rome, Rome, Italy

  • Department of Oncology, Medical Oncology Division, University of Palermo, Palermo, Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Azienda ULSS 9 Treviso, Treviso, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solitary fibrous tumor

Biomarkers

  • N/A

Drug/Treatment

  • dacarbazine Intravenous

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved